EVA Pharma
Menu
  • Home
    • Vision
    • Mission
  • About Us
    • ABOUT EVA GROUP
    • ABOUT EVA PHARMA
    • Quality
    • Meet Our Leaders
  • R&D
  • Products
    • Therapeutic Area
    • Products Portofolio
    • EU-CTD List OCT
  • Covid-19 Products
  • Partnerships
  • News and Media
  • Positive Impact
  • Careers
    • Find a Job
    • Find an Internship
    • Life at Eva pharma
    • Training and Development
  • Contact Us
    • Reach Us
    • Adverse Event Reporting
Search

Products

by THERapeutic AREA
  • All
  • Alimentary T.& Metabolism
  • Blood and Blood Forming Organs
  • Cardiovascular System
  • Dermatologicals
  • G.U. System & Sex Hormones
  • Musculoskeletal System
  • Nervous System
  • Respiratory System
  • Sensory Organs
  • Systemic Anti-ineffective
  • Systemic Hormones
  • Various
Tenaviron 300 mg

Tenaviron 300 mg

Systemic Anti-ineffective
Valysernex 500 mg

Valysernex 500 mg

Systemic Anti-ineffective
Valysernex 1000 mg

Valysernex 1000 mg

Systemic Anti-ineffective
Bactizolid

Bactizolid

Systemic Anti-ineffective
Moxiflox

Moxiflox

Systemic Anti-ineffective
Cefpirome

Cefpirome

Systemic Anti-ineffective

Nucleobuvir 400 mg

Systemic Anti-ineffective
Daclavirdin 60 mg

Daclavirdin 60 mg

Systemic Anti-ineffective
Nucleobuvir Velpa

Nucleobuvir Velpa

Systemic Anti-ineffective
Floxabact 250 mg

Floxabact 250 mg

Systemic Anti-ineffective
  • 1
  • 2
  • Facebook
  • YouTube
  • LinkedIn
  • Facebook
  • YouTube
  • LinkedIn
© Copyright EVA Pharma
  • Home
  • About Us
  • R&D
  • Products
  • Covid-19 Products
  • Partnerships
  • News and Media
  • Positive Impact
  • Careers
  • Contact Us